Anthropic announced 10,000 Claude seats for scientists on August 27, 2026: standard access free, premium $15 per month with about five times the usage, for one year. A seat is access, not a new model. Claude Science is still the workbench; biology and chemistry stay on Opus-class models; Fable still blocks professional biology and drug development. It is not Mythos Glasswing, and it is not an experiment runner.
Claude Researcher is an independent publication and is not affiliated with Anthropic. Flip the card for the refusals. The long explainer is the scientists program page.
The default seat. Same generally available models as any other Claude account, for the one-year program term.
Reverse · void if misread
NOT A CAPABILITY UNLOCK
What this seat is not
Not Glasswing
Not Mythos 5.1 trusted access
Mythos 5.1 / Project Glasswing is a separate trusted-access track. A program seat does not include it.
Not a jailbreak
Not a biology or chemistry exemption
Fable still blocks professional biology and drug development. Those domains stay on Opus-class models.
Not the runner
Not an autonomous experiment loop
Human-run research on Claude Science. The experiment runner lives at claudescientist.com.
Click the card to flip it. Keys: F or space flips, 1 standard, 2 premium, when the credential has focus.
The reverse, written out
A free seat is not a research method.
Not Glasswing
Not Mythos 5.1 trusted access
Mythos 5.1 is the same underlying model as Fable 5.1 with more permissive safeguards, restricted to trusted access / Project Glasswing. Anthropic describes life-sciences trusted access as enrolling its first participants. A scientists-program seat does not include it.
Fable still blocks professional biology and drug-development work. Those requests route to Opus-class models. Opus 5 is the generally available research-capable model for those domains. A seat does not change the public policy, and this page does not describe how to get around it.
A seat is for human-run research on a workbench. Agents that design and execute their own experiments are a different question, owned by Claude Scientist. This site links that lane; it does not reprint the run loop.
Anthropic is offering 10,000 Claude seats to scientists: standard access free, premium at $15 per month, for one year.
What the face of the seat actually grants
Treat the credential as a budget line. It lowers the cost of using Claude on research work for a bounded term. It does not change how citations behave, who is accountable for a published claim, or which model a restricted domain may use. Eligibility, remaining seats, and the application path are the volatile parts of a finite program, so the live announcement is the document to check before anyone plans a year around a seat.
Standard is complimentary. Premium is $15 per month and is described as about five times the usage. That multiplier is usage, not capability: the same generally available lineup, the same workbench, the same safeguards. If a lab needs more headroom, it is buying more tokens on the same models, not a different Claude.
Claude Science is still the workbench the announcement points at. A seat is most useful when the work spans literature, code, data files, and figures, and when those artifacts stay inspectable. Chat remains the wrong place to hide a methods section.
What the reverse is for
Three misreadings keep attaching themselves to this program. The reverse of the card is there so they have to be said in the same breath as the price.
Mythos 5.1 / Project Glasswing is a different track. Mythos is the same underlying model as Fable 5.1 with more permissive safeguards, restricted to trusted access. Life-sciences trusted access is described as enrolling first participants. It is not bundled with a scientists-program seat, and it should not be described as generally available to researchers.
Professional biology and drug development stay blocked on Fable. Those requests route to Opus-class models. Opus 5 is the generally available research-capable model for biology and chemistry. This page states the public policy. It does not provide methods, protocols, or techniques for restricted work.
An autonomous experiment loop is a different site. A human using Claude Science on a literature corpus, a notebook, and a locked evidence table is this lane. An agent designing and executing its own experiments is Claude Scientist. The Seat does not reprint that run loop.
What to set up before the interesting prompts
Free-access programs fail in the first week: enthusiastic usage, no artifact anyone can audit six months later. If the seat is going to produce work that survives review, the scaffolding should exist before the interesting prompts start: a written question with inclusion criteria, searches run in the databases that own the bibliographic record, an evidence table Claude drafts from rather than adds to, and a notebook that records the prompt, the input set, the output, and the human decision.
None of that depends on which model is current, which is why it is worth building during a one-year term. The scientists program explainer, the literature-review workflow, and the lab notebook are the durable pages. This credential is the object you hold up when someone asks what the 10,000 seats actually are.
FAQ
What is the Claude scientists program?
An Anthropic access program announced on August 27, 2026, offering 10,000 Claude seats to scientists for one year: standard access free, and a premium tier at $15 per month described as about five times the usage. It is a seat, not a new model.
Is the scientists program free?
Standard access is free for the program term. The premium tier costs $15 per month. Eligibility, remaining seats, and the application path are on the Anthropic announcement; check that page before planning around a seat.
Does a program seat include Mythos 5.1 or Project Glasswing?
No. Mythos 5.1 is a restricted trusted-access track. Anthropic describes life-sciences trusted access as enrolling its first participants. It is not part of the 10,000 seats.
Can I use Claude Fable 5.1 for professional biology or drug-development research?
No. Fable still blocks professional biology and drug-development work. Those requests route to Opus-class models. Opus 5 is the generally available research-capable model for those domains. A seat does not lift that limit.
Is this the same as an AI scientist running its own experiments?
No. The seat is access for human-run research on Claude Science. Autonomous experiment agents are a separate topic, covered at claudescientist.com. This page links that lane and does not reprint the run loop.
What does a seat change about citations and lab data?
Nothing about the verification burden, and do not assume anything about retention. Confirm which plan, institutional agreement, and retention setting govern the seat before putting unpublished, regulated, or confidential material into any Claude surface.
Claude Researcher is an independent educational publication and is not affiliated with, sponsored by, or endorsed by Anthropic. The credential above is an editorial object. Cite the Anthropic announcement for program terms.